XDWS Stock Price | Xtrackers MSCI World Consumer Staples UCITS ETF 1C P/E, Revenue, EPS, & Forecasts

Xtrackers MSCI World Consumer Staples UCITS ETF 1C • XDWS

XDWS current price

$49.54+18.55%

Capital at risk.

About
Metrics
Sector breakdown
Regional breakdown
Top 10 Holdings
FAQs
News

-2.08%

-1.59%

+6.29%

+10.11%

+18.55%

MAX

+66.47%

About Xtrackers MSCI World Consumer Staples UCITS ETF 1C

Base currency

$ USD

Trading Cyrrency

USD

ISIN

IE00BM67HN09

Trading on

LSE

Ticker

XDWS

Fund manager

Xtrackers

Key facts & metrics

BasicAdvanced

Fund size

$1.08B

income

Distributing

Expense Ratio

25.00%

Dividend Yield

2.64194

Valuation

Price to prospective earnings

20.02

Price to book

1.33

Price to sales

4.13

Price to cashflow

13.56

Price

52-week High

$51.26

52-week Low

$40.91

50-day moving average

$49.24

200-day moving average

$46.67

Technicals

YTD

7.66%

Year 1

8.64%

Year 3

6.48%

Year 5

4.98%

Year 10

0.00%

Volatility Year 1

7.86%

Volatility Year 3

8.62%

Expected Return Year 3

6.30%

Sharpe Ratio

0.32%

Growth

Long term projected earnings

7.23%

Historical earnings

5.76%

Sales

7.72%

Cash flow

6.51%

Book value

3.96%

Sector breakdown

Consumer

% 98,97

Healthcare

% 1,03

Regional breakdown

North America

% 66,26

Europe

% 16,99

% 10,49

Asia

% 4,97

Australia

% 1,29

Top 10 Holdings

Procter & Gamble Company

8.92%

Costco

8.74%

Walmart Inc

7.56%

Coca-Cola Co

6.56%

Nestle

6.34%

PepsiCo

5.25%

Philip Morris International Inc

4.23%

Unilever

3.58%

L’Oreal

2.34%

Mondelez International Inc

2.14%

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

What is the name of XDWS?

The name of XDWS is Xtrackers MSCI World Consumer Staples UCITS ETF 1C.

What is the ticker of Xtrackers MSCI World Consumer Staples UCITS ETF 1C?

The primary ticker of Xtrackers MSCI World Consumer Staples UCITS ETF 1C is XDWS.

What is the ISIN of Xtrackers MSCI World Consumer Staples UCITS ETF 1C?

The ISIN of Xtrackers MSCI World Consumer Staples UCITS ETF 1C is IE00BM67HN09.

What are the costs of Xtrackers MSCI World Consumer Staples UCITS ETF 1C

The total expense ratio (TER) of Xtrackers MSCI World Consumer Staples UCITS ETF 1C amounts to 25.00% p.a. These costs are withdrawn continuously from the fund assets and already included in the performance of the ETF. You don't have to pay them separately.

Does Xtrackers MSCI World Consumer Staples UCITS ETF 1C pay dividends?

Yes, Xtrackers MSCI World Consumer Staples UCITS ETF 1C does pay dividends.

What currency is Xtrackers MSCI World Consumer Staples UCITS ETF 1C traded in?

Xtrackers MSCI World Consumer Staples UCITS ETF 1C is traded in USD.

Is Xtrackers MSCI World Consumer Staples UCITS ETF 1C an accumulating or distributing ETF?

Xtrackers MSCI World Consumer Staples UCITS ETF 1C is distributing.

Who is the fund manager of “Xtrackers MSCI World Consumer Staples UCITS ETF 1C?

The fund manager of Xtrackers MSCI World Consumer Staples UCITS ETF 1C is Xtrackers.

What is the fund size of Xtrackers MSCI World Consumer Staples UCITS ETF 1C?

The fund size of Xtrackers MSCI World Consumer Staples UCITS ETF 1C is $1.08B.

Xtrackers MSCI World Consumer Staples UCITS ETF 1C news

thumb_up_alt

•Positive

Uber ties up with Avride for food deliveries, robotaxi rides

Uber Technologies said on Thursday it was partnering with autonomous technology startup Avride for food deliveries and robotaxi services, as the ride-hail major rapidly extends its network of self-driving technology partners.

Reuters•14h ago

thumbs_up_down

•Neutral

Palvella Therapeutics Awarded Up to $2.6 million Grant from the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development to Support Phase 3 Single-Arm, Baseline-Controlled Trial in Microcystic Lymphatic Malformations

FDA Orphan Products Grants are based on scientific and technical merit as determined by rare disease and regulatory experts

GlobeNewsWire•16h ago

thumb_up_alt

•Positive

Suntory Beverage & Food: Eyes On Profitability Improvement, Capital Allocation

Suntory's operating profit surged 17.6% YoY in 1H 2024, driven by successful cost management and product mix optimization in Japan. Suntory plans to raise its dividend payout ratio to 40% and invest JPY 300-600 billion in capital investments for the FY 2024-2026 period. My rating for Suntory Beverage is a Buy, taking into account the profitability improvement for its Japanese operations and the company's balanced capital allocation approach.

Seeking Alpha•02 Oct 2024, 12:48

Invest your money to its potential

When you invest your capital is at risk.